MONITORING OF OSTEOPOROSIS TREATMENT
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 9
Abstract
Osteoporosis is far the most common metabolic bone disease and is often called the "silent" disease, because bone loss occurs without symptoms. People often don't know they have the disease until bone breaks, following trivial injury. The consequences of osteoporosis are financial, physical, and psychosocial, which significantly affect the individual as well as the family and community. Osteoporosis bone fractures are responsible for considerable pain, decreased quality of life, lost workdays, and disability. Notably, one in five patients is no longer living one year after sustaining an osteoporotic hip fracture. It is projected that the number of hip fractures worldwide will exceed six million by 2050. These facts make osteoporosis a critical health issue and entire world focus has shifted on to osteoporotic fractures. Dual Energy X-ray Absorptiometry (DEXA) has become standard method for determining bone marrow density. By measuring BMD, it is possible to predict fracture risk in the same manner that measuring blood pressure can help predict the risk of stroke. Approximately 10 -15% of patients with osteoporosis fail to respond to treatment. As in most chronic diseases, compliance is usually poor in patients on long term treatment of osteoporosis. Thus, the aim of monitoring should be to increase adherence to treatment as well as to ascertain response to treatment. Because fracture events are uncommon, they cannot be used to monitor drug effectiveness. Repeat BMD measurement especially at the spine, is recommended once every two years to confirm treatment response.
Authors and Affiliations
Ramesh Narula , Tauseef Mujtaba , Aftab Iraqi , Anjana Arya
Keywords
Related Articles
- EP ID EP98097
- DOI -
- Views 70
- Downloads 0
RADIOPHARMACEUTICALS FOR IMAGING OF HYPOXIC TUMORS: A REVIEW
Radiopharmaceuticals are drugs containing a radionuclide and are used routinely in nuclear medicine for the diagnosis and therapy of various diseases. The mechanism of localization of the radiopharmaceutical in differen...
CHELATING PROPERTIES OF CARDIOSPERMUM HALICACABUM AGAINST THE TOXIC EFFECT OF CYPERMETHRIN IN THE QUANTIFICATION OF NUCLEIC ACIDS IN THE FRESH WATER FISH CIRRHINUS MRIGALA (HAMILTON)
Among the pesticides the synthetic pyrethroids are commonly used because of their rapid biodegradability and non-persistent nature. The cypermethrin has a strong pescicidal activity in fresh water fish C. mrigala for al...
KINETICS OF OXIDATION OF SALBUTAMOL BY CHLORAMINE-B IN NaOH MEDIUM: A MECHANISTIC APPROACH
The kinetics of oxidation of salbutamol (SBL) by N-chlorobenzenesulphonamide (CAB) in NaOH medium has been investigated at 303K. The reaction rate shows a first order dependence on [CAB]0 , fractional order with resp...
FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF BAMBUTEROL HYDROCHLORIDE
The aim of the present study was to prepare mouth dissolving tablets of Bambuterol hydrochloride by using pertinent disintegrants. The tablets were prepared using mannitol and lactose along with two levels of disintegran...
SPECTROPHOTOMETRIC ESTIMATION OF GEMFIBROZIL IN BULK AND PHARMACEUTICAL DOSAGE FORMS
A simple, sensitive and accurate UV spectrophotometric method has been developed for the determination of Gemfibrozil in bulk and pharmaceutical tablet dosage formulation. This method obeys Beer’s law in the concentratio...